On April 7th 2019, Dr. Clément Thomas, leader of the Cytoskeleton and Cancer Progression group at LIH, was invited to give a presentation at the workshop "NK cells in cancer therapy: the next breakthrough" held at the Weizmann Institute of Science (Rehovot, Israel).
Dr. Thomas described how targeting the actin cytoskeleton could restore an effective anti-tumor immune response.
 |
 |
Cytoskeleton and Cancer Progression is part of the Department of Oncology
Luxembourg Institute of Health
Copyright 2019, LIH, updated in September 2019
